Ophthalmic Artificial Intelligence-Assisted Diagnosis Market to Reach $4.25 Billion by 2029, Growing at a CAGR of 18.3%
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Ophthalmic Artificial Intelligence-Assisted Diagnosis Industry In 2025?
The ophthalmic artificial intelligence-assisted diagnosis market has experienced swift expansion recently. Projections indicate its expansion from $1.83 billion in 2024 to $2.17 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 18.7%. Key drivers behind its past expansion encompass rising awareness about early diagnosis of ocular disorders, increasing demand for efficient and accurate retinal imaging, rising incidence of diabetic retinopathy, a growing geriatric population, and increasing investment in healthcare infrastructure.
The ophthalmic artificial intelligence-assisted diagnosis market size is projected for substantial expansion in the coming years, anticipated to reach a value of $4.26 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 18.3%. This forecasted expansion is primarily driven by factors such as the expanding application of AI in teleophthalmology, a heightened need for accessible and remote eye care services, increased emphasis on proactive eye health, the rise of remote diagnostics and teleophthalmology, and a growing number of regulatory endorsements for AI-powered ophthalmic instruments. Key developments expected during this period involve enhancements in deep learning algorithms for analyzing retinal images, the creation of innovative portable and self-contained AI eye screening tools, the incorporation of AI diagnostics into electronic health records, breakthroughs in platforms designed for detecting multiple diseases, and the integration of artificial intelligence with telemedicine to facilitate remote eye examinations.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28285&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Industry?
An anticipated increase in eye disorders is set to drive the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the future. These disorders are defined as medical conditions or structural/functional abnormalities of the eye that can compromise vision or overall ocular health. Their escalation is linked to extended screen time from digital devices, leading to digital eye strain, dryness, and prolonged vision problems stemming from prolonged blue light exposure and decreased blinking. Ophthalmic artificial intelligence-assisted diagnosis provides assistance by examining medical imagery and patient data to identify, categorize, and foresee eye disorders precisely and at an early stage, facilitating prompt intervention and lowering the chance of vision loss. For example, in September 2023, the Association of Optometrists, a UK-based representative membership organization, indicated that England recorded 22,552 new certifications for vision impairment in 2022. Among these, 1,344 instances were attributed to diabetic eye disease, 3,614 were connected to glaucoma, and 10,865 related to age-related macular degeneration. Consequently, the growing incidence of eye disorders is fueling the expansion of the ophthalmic artificial intelligence-assisted diagnosis market.
How Is The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Classified Into Different Segments?
The ophthalmic artificial intelligence-assisted diagnosis market covered in this report is segmented as
1) By Type: Cloud-Based, On-Premises
2) By Technology: Deep Learning, Machine Learning, Natural Language Processing (NLP), Computer Vision, Other Technologies
3) By Application: Hospital, Clinic, Imaging Centre
Subsegments:
1) By Cloud-Based: Public Cloud, Private Cloud, Hybrid Cloud
2) By On-Premises: Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment
Which Ongoing Trends Are Expected To Shape The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Outlook?
Leading companies in the ophthalmic artificial intelligence-assisted diagnosis market are focusing on creating innovative solutions, such as an ocular data-as-a-service platform, to enhance diagnostic accuracy, streamline patient care, and enable predictive insights for eye disorders. An ocular data-as-a-service platform refers to a digital solution that provides eye health data on demand, allowing ophthalmologists, clinics, and AI diagnostic tools to access, share, and analyze retinal images and other ocular information remotely for improved diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc., a US-based digital healthcare solutions company, launched IDHea, designed to streamline ophthalmic diagnostics and improve patient outcomes. It’s a cloud-based platform that accelerates AI and digital health innovation by providing fast, secure access to real-world and clinical ocular datasets. It empowers researchers to drive breakthroughs in both eye and systemic disease care by transforming clinical data into actionable, AI-powered insights. Built on the FAST principle – Fast, Accessible, Safe, and Transparent – IDHea enables predictive, personalized, and proactive patient care while upholding rigorous privacy and governance standards.
Who Are The Prominent Global Companies Shaping The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are Canon Medical Systems Corporation, IDx Technologies Inc., Optos PLC, Digital Diagnostics Inc., Ophtai, Oivi Tech Private Limited, Altris Inc., AEYE Health Inc., Eyenuk Inc., JuneBrain Inc., Mediwhale Inc., Mikajaki SA, MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retinarisk, VoxelCloud Inc., Voxeleron LLC, Ikerian AG, Retmarker, and Synapxe Pte Ltd.
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Ophthalmic Artificial Intelligence-Assisted Diagnosis Industry?
North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ophthalmic artificial intelligence-assisted diagnosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28285&type=smp
Browse Through More Reports Similar to the Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market 2025, By The Business Research Company
Diagnostic And Monitoring Ophthalmic Devices And Equipment Market 2025
Ophthalmic Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Ophthalmic Workstations Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ophthalmic-workstations-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
